2025 ACMG Annual Clinical Genetics Meeting Digital Edition
Expand Your Learning with 60+ Hours of Content from the 2025 ACMG Annual Clinical Genetics Meeting Digital Edition.
 
Image For Activity Cover
Availability
On-Demand
2 Courses
Expires on Mar 31, 2027
Cost
ACMG Member: $600.00
Non-Member: $750.00
Postdoc/Trainee (M): $200.00
Postdoc/Trainee (NM): $250.00
Student (M): $200.00
Student (NM): $250.00
Credit Offered
71.25 CME (AMA) Credits
71.25 CME (Other) Credits
71.25 P.A.C.E. Credits
71.25 NSGC Credits

ACMG Annual Clinical Genetics Meeting Digital Edition

Date of Release: April 21, 2025

Expiration Date: March 31, 2027

Credits offered: CME, P.A.C.E.®(Pending), NSGC

Estimate time of completion: 71.25 hours

NSGC credit reports are sent annually (see reporting timeline below).

 

Course Description

The 2025 ACMG Annual Clinical Genetics Meeting Digital Edition will present both research and clinical topics that promote the science and the practice of clinical genetics and genomics. Sessions will focus on the latest discoveries of the etiology and the pathogenesis of genetic disorders, the latest developments in genetic testing and screening, the laboratory’s role in the diagnosis of genetic disorders, the treatment of genetic disorders in children and adults, the delivery of genetic services, and more.

 

Learning Objectives

At the conclusion of this course, participants should be able to:

 

  1. Describe the advances in genetic testing including prenatal and postnatal indications, gene panels, genome sequencing, interpretation, genetic counseling, and ethical and legal issues.
  2. Review select rare and common genetic disorders, from developmental disabilities to cancer predisposition syndromes, as well as novel therapeutic approaches including gene therapy.
  3. Review select inborn errors of metabolism, approaches to their diagnoses and treatment, new disorders on the recommended newborn screening panel.
  4. Recognize the importance of diversity, equity, and Inclusion in clinical genetic care and research, and that inclusion is an essential component for the genetic workforce development.
  5. Analyze the need for innovation and new approaches to transforming the current practice of genetic medicine to achieve a vision of genomically-informed precision population health.

 

Target Audience

All healthcare professionals interested in the diagnosis, management, treatment, and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. The ACMG Annual Meeting is targeted for the following professionals:

  • Medical and clinical geneticists; genetic counselors; pediatric, obstetric, and maternal-fetal specialists; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for patients with, or at risk for, genetically influenced health problems.
  • Laboratory directors and technicians who conduct genetic testing.
  • Researchers involved in the discovery of genetic disorders and treatments.
  • Clinical, laboratory and research trainees of genetics and all biomedical sciences.
  • Any healthcare and public health professionals who have an interest in medical and clinical genetics and genomics.
  • Advocates for patients with genetic conditions and their families.






Session Title

CME | P.A.C.E.® | NSGC

Rare Disease Advisory Councils – State Advocacy for the Rare Disease Community

2.0

Cultivating the Genetic Workforce: The Pipeline Approach

2.0

Back to Basics: The Physical Exam is the Cornerstone of Precision Medicine

2.0

2025 ACMG Foundation Awards and Presidential Plenary Session- Genetics in the Media  Entertainment, Public Education, Controversies and Ethical Dilemmas

1.75

Early Genetics Trainee and Faculty Forum - Clinical Genetics - Where Are We Headed?

 

1.5

The Future of Genetics in Reproductive Medicine: Filling in the Gaps Beyond Aneuploidy and Carrier Screening

 

1.5

Diagnostic Dilemmas from the Undiagnosed Diseases Network

 

1.5

Evolution of Cytogenomic Technology:  Real-World Applications of Optical Genome Mapping in the Laboratory

 

1.5

Genetics in Some Arabic Countries: A Journey of Discoveries, Advances, and Struggles

 

1.5

Looking Ahead: Advances in Ophthalmic Genetics

 

1.5

Navigating the Current Landscape in Prenatal Genetics - Coverage, Politics and Laboratory Practice

 

1.5

Perspectives on Off-Label Use of Therapeutics in Rare Diseases

 

1.5

Shifting the Paradigm to Consider Inherited Cancer Risks on a Continuum Rather than Binary

 

1.5

Platform Session 1: Clinical and Biochemical Genetics and Therapeutics

 

1.5

Cardinal Signs

 

1

Leveraging Digital Technology to Advance Patient Care in Prenatal Genetics

 

1

Featured Platform Presentations

 

1

Platform Session 2: Clinical Genetics and Therapeutics

 

1.5

Platform Session 3: Cancer Genetics and Therapeutics

 

1.5

Platform Session 4: Prenatal and Newborn Genetics

 

1.5

The ACMG/AMP/CAP/ClinGen Standards for Sequence Variant Classification

 

2.0

Ted-Style Talks: Ethical Considerations in Genetics: Balancing Medical Care and Patient Needs in a Culturally Sensitive Way

 

1.0

Identifying Common Issues and Solutions for Clinical Genetics Centers: Discussions in the Medical Director's SIG

 

1.0

Challenges in Variant Science: Experiences from the Perspective of the Variant Scientist

 

1.0

Emerging Therapeutics: Known and Expected Challenges of this New Era

 

1.0

Fetal Fentanyl Syndrome- A Teratogen Induced Embryopathy Masquerading as a Metabolic Disease

 

1.0

Advances in Genetic Predisposition to Childhood Leukemia

 

1.0

Real-World Outcomes of Emerging Therapeutics: What's Happening After the Accelerated FDA Approval?

 

1.0

The Future for Monogenic Neurodevelopmental Disorders: Lessons from Angelman Syndrome and Brain Plasticity

 

1.5

Use of Sex and Gender Identifiers in Clinical and Laboratory Genetics and Genomics (An ELSI and Community, Outreach and Engagement Committee Co-sponsored Session)

 

1.5

Challenge the Experts - Pediatric and Prenatal Diagnostic Dilemmas (Rare Knowns and Unknowns)

 

1.5

Medical Diagnostic Challenges (Adult and Cancer)

 

1.5

Platform Session 5: Neurodevelopmental and Biochemical Genetics

 

1.5

Platform Session 6: Laboratory Genetics

 

1.5

Platform Session 7: Genetic Data, Health Services, and ELSI

 

1.5

Platform Session 8: Genomic Medicine and Education

 

1.5

Laboratory Diagnostic Challenges: Constitutional and Neoplastic Cases in Molecular, Cytogenomic, and Biochemical Genetics Specialties

 

1.5

New Advancements and Trends in Cardiogenomics

 

1.5

Genetics Counselor Forum: Sexual and Reproductive Health Counseling for Individuals with Intellectual Disability

 

1.5

Advances in the Clinical and Laboratory Approaches to Repeat Expansion Disorders

 

1.5

Current Debates in Reproductive Genetics: CNV Reporting in Cell Free Fetal DNA Screening and Genome Sequencing for All

 

1.5

Current Practice and Future Prospects for Autologous Ex Vivo Gene Treatment and HSCT in Lysosomal Storage Disease

 

1.5

Importance of Paired Germline and Tumor Testing in Cancer Patients from Understudied Populations

 

1.5

N of 1 ASO Therapies: The How-Tos of Implementation

 

1.5

The Future of Prenatal Genetics: A Journey Through Emerging Technologies and Ethical Issues

 

1.5

R. Rodney Howell Symposium: Using DNA as a Population Health Screen: ACMG's Efforts to Define a Primary Findings (PF) List for Health Screening

 

2.0

Multidisciplinary Patient-Centered Care for Differences of Sex Development (DSD)

 

1.5

NAMA at ACMG: Unique Adult Presentations and Management of IEM (adults aren't just big kids)

 

1.5

Novel Splice-Driven Mechanisms of Human Genetic Diseases Unveiled by Long-Read RNA-Sequencing

 

1.5

Total Accredited Educational Hours

71.25

CME AMA PRA Category 1 CreditsTM, ASCLS P.A.C.E.®, NSGC

 

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Credit Designation

The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 71.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

 

ASCLS P.A.C.E.® CEU's 

Approval for PACE contact hours is currently pending.

 

National Society of Genetic Counselors (NSGC):

The National Society of Genetic Counselors (NSGC) has authorized American College of Medical Genetics and Genomics (ACMG) to offer up to 7.125 CEUs or 71.25 Category 1 contact hours for the activity 2025 ACMG Annual Clinical Genetics Meeting Digital Edition. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor recertification.

 

ACMG reports completed accredited sessions to NSGC for credit certificates annually.

Reporting year

Participant deadline to claim credits

ACMG reporting date

2025

12/1/2025

12/3/2025

2026

12/1/2026

12/3/2026

2027

3/30/2027

5/28/2027

 

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

 

Participation Instructions (OnDemand)

  1. Complete session by watching recordings.
  2. Pass a post-test with a score of 80% or better (Learning mode activated and reset available).
  3. Complete session evaluations

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.

*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships listed have been mitigated.

Name

Role: Presenter/ Panelist / Moderator / Liaison / Program Committee Member / Peer Reviewer

Financial Disclosure for 24 Months (relationship is ongoing)

Aarabi, Mahmoud

Co-Moderator / Platform Presenter

No Relevant Financial Relationships

Abu-el-haija, Aya

Moderator

No Relevant Financial Relationships

Adam, Margaret

CE Presenter

Consultant: Sanofi Pasteur Inc.; Axome Therapeutic

Aguiar, Isabella

CE Presenter

No Relevant Financial Relationships

Adams, April

CE Presenter / Co-Moderator

No Relevant Financial Relationships

Ajuyah Robertson, Pamela

CE Presenter /Platform Presenter

No Relevant Financial Relationships

Akkari, Yassmine

CE Presenter

Consultant: Qiagen

AlAbdi, Lama

CE Presenter

No Relevant Financial Relationships

Al-Kouatly, Huda

Moderator

No Relevant Financial Relationships

Ali, Asma

CE Presenter

No Relevant Financial Relationships

Allain, Dawn

CE Presenter

No Relevant Financial Relationships

Al-Maraghi, Aljazi

CE Presenter

No Relevant Financial Relationships

Barnes, Erica

CE Presenter

No Relevant Financial Relationships

Barnett, Claudia

Program Committee Member

No Relevant Financial Relationships

Barr, Eileen

CE Presenter

No Relevant Financial Relationships

Bates, Sarah

CE Presenter

No Relevant Financial Relationships

Beaudet, Arthur

CE Presenter

Owner/Founder relationship with Luna Genetics 2019-2023; Has ended

Beck, Christine

CE Presenter

No Relevant Financial Relationships

Belkin, Lisa

CE Presenter

No Relevant Financial Relationships

Ben Moshe, Yishay

Platform Presenter

No Relevant Financial Relationships

Bereshneh, Ali

Platform Presenter

No Relevant Financial Relationships

Berent, Allyson

CE Presenter

Consultant: Ionis Pharmaceuticals; Pharmaceuticals Encoded Therapeutics; Neuren; Taysha Gene Therapies

Berry-Kravis, Elizabeth

CE Presenter

Research: Tetra Therapeutics; Zynerba Pharmaceuticals; Taysha Gene Therapies; Ultragenyx; Roche; Ionis Pharmaceuticals; Zevra Therapeutics; Acadia Pharmaceuticals Inc.; Neuren Pharmaceuticals; Biomarin Pharmaceutical Inc.; SMA: Roche; Ionis Pharmaceuticals; Zevra Therapeutics; Neurogene; Neuren Pharmaceuticals; Novartis; Encoded Therapeutics

Biesecker, Leslie

CE Presenter

Research: Merck; Ethics Board: Illumina, Inc.

Bird, Lynne

Moderator

Research: F Hoffman LaRoche; Ultragenyx; Ionis Pharmaceuticals; Soleno Therapeutics Inc.; Acadia Pharmaceuticals Inc.; Aardvark Therapeutics, Inc.; SMA: Soleno Therapeutics Inc.; Neuren Pharmaceuticals; Consultant:  Sage Therapeutics; Ionis Pharmaceuticals

Botto, Lorenzo

CE Presenter

No Relevant Financial Relationships

Bouknight, Janet

CE Presenter

No Relevant Financial Relationships

Bowling, Kevin

Moderator

No Relevant Financial Relationships

Boyd, Brenna

Platform Presenter

No Relevant Financial Relationships

Brady, Jordan

CE Presenter

No Relevant Financial Relationships

Branham, Kari

CE Presenter

Consultant: Janssen Pharmaceuticals
Research: Janssen Pharmaceuticals

Breman, Amy

CE Presenter

No Relevant Financial Relationships

Breton, Jacquelynn

CE Presenter

Disclosure information pending

Brewer, Casey

CE Presenter

No Relevant Financial Relationships

Burke, David

CE Presenter

No Relevant Financial Relationships

Burns, William

Co-Moderator

No Relevant Financial Relationships

Burnside, Rachel

CE Presenter

SMA: Sivotech Bioinformatics LLC; Consultant: Nabsys Inc

Burrage, Lindsay

Platform Presenter

No Relevant Financial Relationships

Byrne, Alicia

CE Presenter

No Relevant Financial Reationships

Cantor, Andy

CE Presenter

Employee: Labcorp

Carter, Lauren

CE Presenter

No Relevant Financial Relationships

Casillan, Aimiel

Platform Presenter

No Relevant Financial Relationships

Cassini, Thomas

Moderator

No Relevant Financial Relationships

Castaldi, Peter

CE Presenter

Research: Sanofi Pasteur Inc.
Consultant: Genentech

Castro, Matheus

CE Presenter

No Relevant Financial Relationships

Cayton-Vaught, Kamaria

CE Presenter

No Relevant Financial Relationships

Chahal, Anwar

CE Presenter

No Relevant Financial Relationships

Chopra, Maya

Platform Presenter

No Relevant Financial Relationships

Chung, Wendy

CE Presenter /Platform Presenter

SMA: Prime Medicine; Oxford Nanopore Technologies, Grant/Research Support

Church, Alanna

CE Presenter

No Relevant Financial Relationships

Cizek, Stephanie

CE Presenter

No Relevant Financial Relationships

Cohen, Jenna

Program Committee Member

No Relevant Financial Relationships

Collier, Rachel

Platform Presenter

No Relevant Financial Relationships

Cooperstein, Isabelle

Platform Presenter

No Relevant Financial Relationships

Cousin, Margot

CE Presenter

No Relevant Financial Relationships

Craig, David

CE Presenter

No Relevant Financial Relationships

Cramm, Jessica

Platform Presenter

No Relevant Financial Relationships

Culver, Julie

CE Presenter

No Relevant Financial Relationships

Curry, Cynthia

CE Presenter

No Relevant Financial Relationships

Dahlroth, Jane

Program Committee Member

No Relevant Financial Relationships

Davis, Shanlee

Platform Presenter

Research: Ascendis Pharma

Dawood, Moez

Platform Presenter

No Relevant Financial Relationships

de Smith, Adam

CE Presenter

No Relevant Financial Relationships

Délot, Emmanuèle

CE Presenter

Stocks: Pacific Biosciences

Desai, Mehul

CE Presenter

No Relevant Financial Relationships

Dhar, Shweta

Program Committee Member / CE Presenter

No Relevant Financial Relationships

Dickson, Alexa

CE Presenter

No Relevant Financial Relationships

Ding, Qiliang (Andy)

Platform Presenter

No Relevant Financial Relationships

Dinulos, Mary Beth

CE Presenter

No Relevant Financial Relationships

Dipple, Katrina

Co-Moderator

Research: GeneDx

DiStefano, Marina

CE Presenter

No Relevant Financial Relationships

Eddleman, Keith

Moderator

Speaker's Bureau: Mead Johnson & Company, LLC

El-Khattabi, Laila

CE Presenter

No Relevant Financial Relationships

Ellinwood, N. Matthew

CE Presenter

Consultant: Denali Therapeutics Inc.; Regenxbio Inc.; Takeda Pharmaceuticals U.S.A., Inc.; Biomarin Pharmaceutical Inc.; Orchard Therapeutics Ltd.

Faghfoury, Hanna

CE Presenter

No Relevant Financial Relationships

Farrell, Ruth

CE Presenter

No Relevant Financial Relationships

Felker, Stephanie

Platform Presenter

No Relevant Financial Relationships

Felton, Colette

CE Presenter

No Relevant Financial Relationships

Fernandes, Erica

CE Presenter

No Relevant Financial Relationships

Flanigan, Kevin

CE Presenter

No Relevant Financial Relationships

Frank, Katie

CE Presenter

No Relevant Financial Relationships

Freire, Penelope

Program Committee Member

No Relevant Financial Relationships

Friedman, Leor

CE Presenter

No Relevant Financial Relationships

Gaviglio, Amy

CE Presenter

Speaker's Bureau: Orchard Therapeutics Ltd.; Takeda Pharmaceuticals U.S.A., Inc.
SMA: Sanofi Pasteur Inc.

Furuta, Yutaka

Platform Presenter

No Relevant Financial Relationships

Gerber, Rachel

CE Presenter

No Relevant Financial Relationships

Ghosh, Rajarshi

Program Committee Member

Stocks: 3M Company; Anavex Life Sciences; GeneDx, Inc.; Pacific Biosciences

Giordano, Jessica

CE Presenter

No Relevant Financial Relationships

Giusti-Rodriguez, Paola

CE Presenter

No Relevant Financial Relationships

Glazer, Andrew

CE Presenter

No Relevant Financial Relationships

Gomez-ospina, Natalia

CE Presenter

SMA: Embold Therapeutics

Gold, Nina

Platform Presenter

No Relevant Financial Relationships

Grange, Dorothy

CE Presenter

No Relevant Financial Relationships

Gray, Kathryn

Moderator

SMA: BillionToOne, Inc.

Gripp, Karen

Moderator

No Relevant Financial Relationships

Grody, Wayne

CE Presenter

No Relevant Financial Relationships

Gu, Shen

Platform Presenter

No Relevant Financial Relationships

Guan, Bin

CE Presenter

No Relevant Financial Relationships

Guha, Saurav

Moderator / CE Presenter

No Relevant Financial Relationships

Haldeman-Englert, Chad

Moderator

No Relevant Financial Relationships

Hamosh, Ada

Platform Presenter

No Relevant Financial Relationships

Harding, Cary

CE Presenter / Platform Presenter

SMA: BioMarin Pharmaceutical Inc.; Sanofi Genzyme; Ultragenyx

Harmatz, Paul

CE Presenter

Consultant: Neurogene; Research: Ascendis Pharma Inc.; ASPA; Azafaros; Biomarin Pharmaceutical Inc.; Calcilytics; Denali Therapeutics Inc.; Orphazyme; Qed Therapeutics; Regenxbio Inc.; Sangamo Therapeutics; Takeda Pharmaceuticals U.S.A., Inc.; Idorsia Pharmaceuticals US Inc; Prevail Therapeutics; Allievex Corporation; GC Biopharma USA, Inc.

Harr, Margaret

Platform Presenter

No Relevant Financial Relationships

Harrison, Steven

CE Presenter

Employee: Ambry Genetics
(Content is unrelated to the company's business line.)

Hercher, Laura

CE Presenter

No Relevant Financial Relationships

Herrity, Allison

CE Presenter

No Relevant Financial Relationships

Hisama, Fuki

Co-Moderator

DSMB: Larimar Therapeutics

Hoffman, Danielle

Platform Presenter

No Relevant Financial Relationships

Hoffman, Jodi

Program Committee Member / Liaison / Peer Reviewer / Moderator

No Relevant Financial Relationships

Hoover-Fong, Julie

Platform Presenter

Consultant: Biomarin; QED; Research: Biomarin; QED; Innoskel; SMA: Biomarin; QED

Hoppman, Nicole

Moderator / CE Presenter

No Relevant Financial Relationships

Hou, Ying-Chen Claire

Platform Presenter

No Relevant Financial Relationships

Hufnagel, Robert

CE Presenter

No Relevant Financial Relationships

Hurst, Anna

Program Committee Member / CE Presenter

Consultant: CFD Research Corporation

Irons, Mira

CE Presenter

No Relevant Financial Relationships

Jayaraman, Vijayakumar

CE Presenter

No Relevant Financial Relationships

Jhuraney, Ankit

CE Presenter

No Relevant Financial Relationships

Jiang, Yong-Hui

Moderator

No Relevant Financial Relationships

Johnson, Erin

CE Presenter

No Relevant Financial Relationships

Jones, Simon

CE Presenter

Consultant:  Orchard Therapeutics Ltd.
Independent contractor: Denali Therapeutics Inc.

Kaiwar, Charu

Moderator

No Relevant Financial Relationships

Kanagal-Shamanna, Rashmi

CE Presenter

No Relevant Financial Relationships

Keegan, Catherine

CE Presenter

No Relevant Financial Relationships

Kelkar, Janhawi

CE Presenter

No Relevant Financial Relationships

Kelly, Nicole

Platform Presenter

No Relevant Financial Relationships

Khan, Aneal

Platform Presenter

No Relevant Financial Relationships

Khushf, George

CE Presenter

No Relevant Financial Relationships

Kim, Adriel

CE Presenter

No Relevant Financial Relationships

Kim, Jaeseung

Program Committee Member / Liaison / Peer Reviewer

No Relevant Financial Relationships

Kim, Raymond

Platform Presenter

No Relevant Financial Relationships

King, Jennifer

Program Committee Member

Sonio

Klugman, Susan

Program Committee Member / Liaison / Peer Reviewer / Moderator / CE Presenter

No Relevant Financial Relationships

Koeberl, Dwight

CE Presenter

Consultant: Bayer Healthcare LLC; Asklepios Biopharmaceutical, Inc.
Owner/Founder: Biotherapeutics, Inc.; Has ended
Royalties: Asklepios Biopharmaceutical, Inc.;
Research: Moderna TX, Inc.; SMA: Takeda Pharmaceuticals U.S.A., Inc.

Kopp, Nathan

Program Committee Member / Liaison / Peer Reviewer

No Relevant Financial Relationships

Korf, Bruce

Moderator

SMA: Springworks Therapeutics; Infixion Bioscience
Speaker's Bureau: Alexion Pharmaceuticals, Inc.

Korson, Mark

CE Presenter

Research: Recordati Rare Diseases, Inc.;
Consultant:  Hemoshear Therapeutics LLC; Zevra Therapeutics

Krakow, Deborah

Panelist

No Relevant Financial Relationships

Kullo, Iftikhar

CE Presenter

No Relevant Financial Relationships

Kuniholm, Ashley

CE Presenter

No Relevant Financial Relationships

Landstrom, Andrew

CE Presenter

No Relevant Financial Relationships

Lathi, Ruth

CE Presenter

No Relevant Financial Relationships

Lauffer, Marlen

CE Presenter

No Relevant Financial Relationships

Lee, Kerry

CE Presenter

Disclosure information pending

Lemke, Amy

Program Committee Member

No Relevant Financial Relationships

Lenz, Heinz Josef

CE Presenter

No Relevant Financial Relationships

Leung, Marco

Moderator

No Relevant Financial Relationships

Levin, Alex

CE Presenter

No Relevant Financial Relationships

Li, Dong

Platform Presenter

No Relevant Financial Relationships

Li, Guozhuang

Platform Presenter

No Relevant Financial Relationships

Li, Hong

Moderator

Independent contractor: Logicbio Therapeutics; Travere Therapeutics, Inc.

Ligon, Azra

CE Presenter

No Relevant Financial Relationships

Lozano, Reymundo

Platform Presenter

No Relevant Financial Relationships

Lupo, Philip

CE Presenter

No Relevant Financial Relationships

Luquetti, Daniela

CE Presenter

No Relevant Financial Relationships

Lyon, Gholson

Platform Presenter

No Relevant Financial Relationships

Macnamara, Ellen

CE Presenter

No Relevant Financial Relationships

Mak, Julie

CE Presenter

No Relevant Financial Relationships

Malin, Jennifer

CE Presenter

No Relevant Financial Relationships

Manickam, Kandamurugu

Program Committee Member / Liaison / Peer Reviewer / CE Presenter

No Relevant Financial Relationships

Manickavasagam Amudhavalli, Shivarajan

Program Committee Member / Liaison / Peer Reviewer

No Relevant Financial Relationships

Manolio, Teri

Program Committee Member / Liaison / Peer Reviewer

No Relevant Financial Relationships

Matalon, Dena

CE Presenter

No Relevant Financial Relationships

Maucere, Lauren

CE Presenter

No Relevant Financial Relationships

McCandless, Shawn

CE Presenter

Consultant: CAMP4 Therapeutics
Research: Ardvark Therapeutics; Rhythm Pharmaceuticals; Harmony Biosciences; Acadia Pharmaceuticals Inc.; Ultragenyx; iECURE

McGowan, Michelle

CE Presenter

No Relevant Financial Relationships

Meier, Grace

CE Presenter

No Relevant Financial Relationships

Meyn, Stephen

CE Presenter

Stocks: Gene42 (Phenotips)

Mirnics, Karoly

CE Presenter

No Relevant Financial Relationships

Monteiro, Alvaro

CE Presenter

No Relevant Financial Relationships

Morales Corado, Andrés

Program Committee Member / Moderator / CE Presenter

Research: Phoenix Nest Inc

Morava-Kosicz, Eva

CE Presenter

No Relevant Financial Relationships

Morgan, Alexis

Program Committee Member

No Relevant Financial Relationships

Mori, Mari

Moderator

No Relevant Financial Relationships

Muchmore, Brian

Platform Presenter

No Relevant Financial Relationships

Murray, Michael

Moderator / CE Presenter

No Relevant Financial Relationships

Neira, Juanita

Moderator

No Relevant Financial Relationships

Newsom, Cassandra

Platform Presenter

Research: Neuren Pharmaceuticals

Nickels, Eric

CE Presenter

No Relevant Financial Relationships

Niehaus, Annie

Moderator

No Relevant Financial Relationships

Nguyen, Quan

Platform Presenter

No Relevant Financial Relationships

Oglesbee, Devin

Moderator

No Relevant Financial Relationships

Olson, Malia

Platform Presenter

No Relevant Financial Relationships

Padeganeh, Abbie

CE Presenter

No Relevant Financial Relationships

Pal, Tuya

CE Presenter

No Relevant Financial Relationships

Pan, Xueyang

Platform Presenter

No Relevant Financial Relationships

Parikh, Aditi

Program Committee Member / Liaison / Peer Reviewer / Moderator

No Relevant Financial Relationships

Penon Portmann, Monica

CE Presenter

No Relevant Financial Relationships

Petrasek, Alexndra

CE Presenter

No Relevant Financial Relationships

Phornphutkul, Chanika

Program Committee Member / Liaison / Peer Reviewer

No Relevant Financial Relationships

Pilgrim-Grayson, Catherine

CE Presenter

No Relevant Financial Relationships

Ponce Hidalgo, Jessica

CE Presenter

No Relevant Financial Relationships

Poskanzer, Sheri

Moderator

No Relevant Financial Relationships

Powell, Cynthia

CE Presenter

No Relevant Financial Relationships

Powell, Sabrina

CE Presenter

No Relevant Financial Relationships

Prasov, Lev

CE Presenter

No Relevant Financial Relationships

Pritchard, Amanda

Moderator

Research: Moderna TX, Inc.

Quintero-rivera, Fabiola

Moderator

No Relevant Financial Relationships

Raca, Gordana

Moderator / CE Presenter

No Relevant Financial Relationships

Radford, Jane

Program Committee Member

No Relevant Financial Relationships

Rahm, Alanna

Program Committee Member / Liaison

No Relevant Financial Relationships

Rajan Babu, Indhu Shree

CE Presenter

No Relevant Financial Relationships

Rajkovic, Aleks

CE Presenter

No Relevant Financial Relationships

Rana, Huma

Moderator

No Relevant Financial Relationships

Rasmussen, Sonja

Co-Moderator

SAC: Pfizer Inc.; Novo Nordisk Inc.; Harmony Biosciences; Axsome Therapeutics; Myovant Sciences Ltd.
Royalties: UpToDate

Rebaiz, Lina

CE Presenter

No Relevant Financial Relationships

Reddi, Honey

CE Presenter

Employee: Belay Diagnostics
(Content is unrelated to the company's business line.)

Rehm, Heidi

CE Presenter

Research: Microsoft

Reich, Daniel

CE Presenter

No Relevant Financial Relationships

Reimers, Rebecca

CE Presenter

No Relevant Financial Relationships

Rippert, Alyssa

Platform Presenter

No Relevant Financial Relationships

Robin, Nathaniel

Moderator

No Relevant Financial Relationships

Rowsey, Ross

Program Committee Member / Liaison / Peer Reviewer / CE Presenter

No Relevant Financial Relationships

Russo, Melissa

Moderator

No Relevant Financial Relationships

Ryall, Scott

Moderator

Speaker: Bionano Genomics, Inc.

Ryten, Mina

CE Presenter

No Relevant Financial Relationships

Sahajpal, Nikhil

CE Presenter

No Relevant Financial Relationships

Sarpatwari, Ameet

CE Presenter

No Relevant Financial Relationships

Saunders, Carol

Platform Presenter

No Relevant Financial Relationships

Savage, Sarah

CE Presenter

No Relevant Financial Relationships

Schelhaas, Andrea

Program Committee Member / Liaison / Peer Reviewer / Moderator / CE Presenter

Consultant: Tyra Science

Schimmenti, Lisa

CE Presenter

No Relevant Financial Relationships

Seibel, Erin

CE Presenter

No Relevant Financial Relationships

Seifert, Bryce

CE Presenter / Co-Moderator

No Relevant Financial Relationships

Sen, Kuntal

CE Presenter

No Relevant Financial Relationships

Senaratne, T. Niroshi

CE Presenter

No Relevant Financial Relationships

Shelkowitz, Emily

CE Presenter

No Relevant Financial Relationships

Shenbagam, Shruti

CE Presenter

No Relevant Financial Relationships

Sheppard, Sarah

Co-Moderator

No Relevant Financial Relationships

Sheynkman, Gloria

CE Presenter

No Relevant Financial Relationships

Shyr, Cathy

Platform Presenter

No Relevant Financial Relationships

Sigdel, Manisha

CE Presenter

No Relevant Financial Relationships

Simpson, Brittany

CE Presenter

No Relevant Financial Relationships

Sinha, Pawan

CE Presenter

No Relevant Financial Relationships

Smith, Adam

Moderator

Stocks: Bionano Genomics, Inc.

St. Clair, Pepper

Platform Presenter

No Relevant Financial Relationships

Stander, Zinandre

CE Presenter

No Relevant Financial Relationships

Stewart, Douglas

CE Presenter

No Relevant Financial Relationships

Summerlin, Maxwell

Moderator

No Relevant Financial Relationships

Symonds, Esteban

Moderator

No Relevant Financial Relationships

Tabor, Holly

CE Presenter

No Relevant Financial Relationships

Tadros, Rafik

Co-Moderator

Consultant and Research: BMS Canada

Taliercio, Vanina

CE Presenter

No Relevant Financial Relationships

Tayeh, Marwan

Program Committee Member / Liaison / Peer Reviewer

No Relevant Financial Relationships

Thompson, Katarzyna

Program Committee Member / Liaison / Peer Reviewer / Co-Moderator

No Relevant Financial Relationships

Thompson, Whitney

Platform Presenter

No Relevant Financial Relationships

Thorsen, Margaret

CE Presenter

No Relevant Financial Relationships

Tise, Christina

Moderator

No Relevant Financial Relationships

Torretto, Gabriella

Platform Presenter

No Relevant Financial Relationships

Toruner, Gokce

CE Presenter

No Relevant Financial Relationships

Tsai, Anne Chun-Hui

CE Presenter

No Relevant Financial Relationships

Tu, Shao Ching

CE Presenter

No Relevant Financial Relationships

Van Den Veyver, Ignatia

CE Presenter

No Relevant Financial Relationships

Velez-Bartolomei, Frances

CE Presenter

No Relevant Financial Relationships

Venditti, Charles

Platform Presenter

No Relevant Financial Relationships

Vengoechea, Jaime

Moderator

No Relevant Financial Relationships

Vergano, Samantha

CE Presenter

No Relevant Financial Relationships

Vilain, Eric

CE Presenter

No Relevant Financial Relationships

Vincent, Lisa

Moderator

Employee: Natera, Inc.
(Content is unrelated to the company's business line.)

Viskochil, David

Moderator

Consultant: AstraZeneca
Research: Springworks Therapeutics; Soleno Therapeutics, Inc.; Levo Therapeutics

Vockley, Jerry

CE Presenter

Research: Ultragenyx; Rene Pharmaceutical Pvt. Ltd.

Vora, Neeta

CE Presenter

Grant: Illumina, Inc.

Wadman, Erin

CE Presenter

No Relevant Financial Relationships

Wang, Christiana

Platform Presenter

No Relevant Financial Relationships

Wang, Raymond

Moderator

Research: Biomarin Pharmaceutical Inc.
Stocks: Biomarin Pharmaceutical Inc.; Sarepta Therapeutics, Inc.; SMA: M6P Therapeutics

Wasserstein, Melissa

Platform Presenter

Consultant: Sanofi

Weidler Baimbridge, Erica

CE Presenter

No Relevant Financial Relationships

Weinstock, Nadav

CE Presenter

No Relevant Financial Relationships

Weisburd, Ben

CE Presenter

No Relevant Financial Relationships

Weisshappel, Kaitlin

Co-Moderator

No Relevant Financial Relationships

Wells, Melanie

Program Committee Member

No Relevant Financial Relationships

Whelan, Colleen

Program Committee Member

No Relevant Financial Relationships

Wilcox, William

CE Presenter

Independent contractor: Sanofi Genzyme; Biomarin Pharmaceutical Inc.; Amicus Therapeutics, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; Chiesi USA, Inc.; Sangamo Therapeutics; 4D Molecular Therapeutics; Alexion Pharmaceuticals, Inc.; Amgen Inc.; Astellas Pharma Inc; Cyclo Therapeutics, Inc.; Denali Therapeutics Inc.
Consultant: Spark Therapeutics, Inc.; Uniqure Biopharm B.V.; Relay Therapeutics

Wojcik, Monica

Platform Presenter

No Relevant Financial Relationships

Wong, Derek

Platform Presenter

No Relevant Financial Relationships

Yinghui, Ye

Platform Presenter

No Relevant Financial Relationships

Yu, Kristen

Platform Presenter

No Relevant Financial Relationships

Zayhowski, Kimberly

CE Presenter

No Relevant Financial Relationships

Zepeda Mendoza, Cinthya

CE Presenter

No Relevant Financial Relationships

Zhu, Jingqi

Platform Presenter

No Relevant Financial Relationships


 

© 2025 American College of Medical Genetics and Genomics. All rights reserved.

Powered By